Journal of Antimicrobial Chemotherapy (2000) 45, 387-394
© 2000 The British Society for Antimicrobial Chemotherapy
Antimicrobial practice |
Use of a treatment protocol in the management of community-acquired lower respiratory tract infection
a Pharmacy Practice Research Group, School of Pharmacy, The Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL; b Antrim Hospital Academic Pharmacy Practice Unit, Antrim Area Hospital; c Department of Microbiology, United Hospital Group Trust; d Department of Medicine, Antrim Area Hospital, Bush Road, Antrim BT41 2RL, UK
Abstract
The aim of the present study was to examine the impact of an antimicrobial prescribing protocol on clinical and economic outcome measures in hospitalized patients with community-acquired lower respiratory tract infection (LRTI). The study was performed as a prospective controlled clinical trial within the medical wards at Antrim Area Hospital, Northern Ireland. Data were collected on all hospitalized adult patients with a primary diagnosis of LRTI during the period December 1994 to February 1995 (normal hospital practice; control group; n = 112). After an LRTI management protocol (medical, microbiological and pharmacy staff) had been developed, all hospitalized adult patients with a primary diagnosis of LRTI over the period December 1995 to February 1996 formed the intervention group (treated according to the protocol; n = 115). The results showed a statistically significant impact of the protocol in terms of clinical and economic outcome measures. Patients treated using the algorithmic prescribing protocol had significant reductions in length of hospital stay (geometric mean 4.5 versus 9.2 days), iv drug administration (34.8% versus 61.6%), duration of iv therapy (geometric mean 2.1 versus 5.7 days) and treatment failures (7.8% versus 31.3%). Healthcare costs were also significantly reduced. The use of the protocol was a major factor in streamlining the prescribing of antimicrobial therapy for community-acquired LRTI and led to more cost-effective patient management.
Notes
* Corresponding author. Tel: +44-1232-335800; Fax: +44-1232-247794; E-mail: j.mcelnay{at}qub.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P.-J. Cortoos, S. Simoens, W. Peetermans, L. Willems, and G. Laekeman Implementing a hospital guideline on pneumonia: a semi-quantitative review Int. J. Qual. Health Care, December 1, 2007; 19(6): 358 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hand Antibiotic pharmacists in the ascendancy J. Antimicrob. Chemother., August 1, 2007; 60(suppl_1): i73 - i76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.M. McLaughlin, N. Bodasing, A.C. Boyter, C. Fenelon, J.G. Fox, and R.A. Seaton Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study QJM, October 1, 2005; 98(10): 745 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Drummond and D. R. Jenkins Treatment protocols for community-acquired pneumonia: evidence-based must replace consensus-based J. Antimicrob. Chemother., October 1, 2000; 46(4): 640 - 641. [Full Text] [PDF]
|
|